By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Pew PatriotsPew PatriotsPew Patriots
Notification Show More
Font ResizerAa
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Reading: First GLP-1 pill for weight loss, diabetes shows success in late-phase trial
Share
Font ResizerAa
Pew PatriotsPew Patriots
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Search
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Have an existing account? Sign In
Follow US
First GLP-1 pill for weight loss, diabetes shows success in late-phase trial
News

First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

Jimmie Dempsey
Last updated: April 17, 2025 8:19 pm
Jimmie Dempsey Published April 17, 2025
Share
SHARE

Injectables for type 2 diabetes and weight loss could soon be a thing of the past.

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill.

The ACHIEVE-1 trial evaluated the efficacy of Orforglipron compared to placebo in adults with type 2 diabetes and “inadequate glycemic control with diet and exercise alone.”

FAKE OZEMPIC DRUGS FOUND IN US DRUG SUPPLY, FDA WARNS

The results showed lowered A1C (blood sugar) in patients by an average of 1.3% to 1.6% across doses, according to a press release.

More than 65% of participants taking the highest dose of the drug scored an A1C less than or equal to 6.5%, which is below the defined threshold for diabetes, according to the American Diabetes Association.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Trial participants also saw reduced weight by an average of 16 pounds, or 7.9%, at the highest dose.

Participants had not reached a weight plateau when the study ended, which suggests there was still weight to be lost, according to the researchers.

Eli Lilly

The trial also found that the overall safety and tolerability of the drug was consistent with the classic injectable GLP-1s, like Ozempic, Wegovy, Mounjaro and Zepbound.

If Orforglipron achieves approval by the U.S. Food and Drug Administration, Eli Lilly projected its confidence in launching the drug “worldwide without supply constraints.”

For more Health articles, visit www.foxnews.com/health

“This would further Lilly’s mission to reduce chronic diseases like type 2 diabetes, which is expected to impact an estimated 760 million adults by 2050,” the pharmaceutical company wrote in its announcement.

GLP-1 syringe

David A. Ricks, Eli Lilly chair and CEO, commented in a statement, “We are pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control and weight loss, and we look forward to additional data readouts later this year.”

“As a convenient once-daily pill, Orforglipron may provide a new option and, if approved, could be readily manufactured and launched at scale for use by people around the world.”

  

Eli Lilly intends to submit Orforglipron for weight management to global regulatory agencies by the end of 2025, as well as for type 2 diabetes treatment in 2026, according to the company.

Read the full article here

You Might Also Like

Pentagon officials blast Washington Post for putting ‘lives at risk’ with report on Pete Hegseth’s security

Trump’s Middle East tour begins with Syria looming as strategic opportunity

Trump buries Biden foreign policy in first 100 days

Russia’s Medvedev says Europe’s ‘coalition of the willing’ failed to outplay Trump after Zelenskyy meeting

Charlie Sheen admits he’s been celibate for nearly a decade since getting sober

Share This Article
Facebook Twitter Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We Recommend
Seahawks stave off Cardinals with game-winning field goal in thrilling win on the road
News

Seahawks stave off Cardinals with game-winning field goal in thrilling win on the road

Jimmie Dempsey Jimmie Dempsey September 26, 2025
First Look: Smith & Wesson 500 Emergency Kit
Zelenskyy ‘ready’ to exit office if war ends, open to elections in ceasefire
First Look: Vortex Venom Enclosed Micro Red Dot
Trump says Comey ‘placed a cloud over the entire nation’ with Crossfire Hurricane, reacts to indictment
Comey indictment sparks fierce political reactions nationwide
Tim Allen says Erika Kirk’s memorial speech inspired him to forgive his father’s killer
News

Tim Allen says Erika Kirk’s memorial speech inspired him to forgive his father’s killer

Jimmie Dempsey Jimmie Dempsey September 26, 2025
Jack Wolf Gets into a Scuffle with Nitch Designs
Guns and Gear

Jack Wolf Gets into a Scuffle with Nitch Designs

Jimmie Dempsey Jimmie Dempsey September 25, 2025
33 Things Everyone Should Start Hoarding
Prepping & Survival

33 Things Everyone Should Start Hoarding

Jimmie Dempsey Jimmie Dempsey September 25, 2025
Pew Patriots
  • News
  • Tactical
  • Prepping & Survival
  • Videos
  • Guns and Gear
2024 © Pew Patriots. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?